Testosterone transdermal - Viramal

Drug Profile

Testosterone transdermal - Viramal

Alternative Names: TestoCream

Latest Information Update: 25 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Viramal
  • Class Androstenols; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone agonists; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Hypogonadism

Highest Development Phases

  • Phase III Hypogonadism

Most Recent Events

  • 18 May 2016 Testosterone transdermal - Viramal is available for licensing in USA as of 18 May 2016. www.viramal.com
  • 18 May 2016 Phase-III clinical trials in Hypogonadism in USA before May 2016 (Topical)
  • 18 May 2016 Viramal has patent protection for drug delivery technology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top